general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be hospitalized or eligible for hospitalization on clinical grounds - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be hospitalized or eligible for hospitalization on clinical grounds - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general